Brief: Samsung Engineering Says Receives Letter of Intent from Samsung Biologics For Building Project Worth $689 Mln
Oct 21 (Reuters) -
* SAMSUNG ENGINEERING SAYS RECEIVES LETTER OF INTENT FROM
SAMSUNG
BIOLOGICS FOR BUILDING PROJECT WORTH 780 BLN WON($688.52
million)
Source text for Eikon: https://bit.ly/3kkwLG5
Further company coverage: 028050.KS
($1 = 1,132.8600 won)
((Heekyong.Yang@thomsonreuters.com;))
Recent news on Samsung E&A Co
See all newsSouth Korean construction and engineering stocks rise on anticipated investment plans
Samsung readies $648 billion bet, report says, as AI boom reshapes South Korea (updated)
Nvidia to supply more than 260,000 Blackwell AI chips to South Korea
South Korea to deploy over 260,000 of Nvidia's latest AI chips, presidential office says
Brief: Samsung E&A Co Wins 251 Billion Won Contract